Bayesian Optimization of Antibodies Informed by a Generative Model of Evolving Sequences
Alan Nawzad Amin Nate Gruver Yilun Kuang Yucen Lily Li Hunter Elliott Calvin McCarter Aniruddh Raghu Peyton Greenside Andrew Gordon Wilson
To build effective therapeutics, biologists iteratively mutate antibody sequences to improve binding and stability. Proposed mutations can be informed by previous measurements or by learning from large antibody databases to predict only typical antibodies. Unfortunately, the space of typical antibodies is enormous to search, and experiments often fail to find suitable antibodies on a budget. We introduce Clone-informed Bayesian Optimization (CloneBO), a Bayesian optimization procedure that efficiently optimizes antibodies in the lab by teaching a generative model how our immune system optimizes antibodies. Our immune system makes antibodies by iteratively evolving specific portions of their sequences to bind their target strongly and stably, resulting in a set of related, evolving sequences known as a *clonal family*. We train a large language model, CloneLM, on hundreds of thousands of clonal families and use it to design sequences with mutations that are most likely to optimize an antibody within the human immune system. We propose to guide our designs to fit previous measurements with a twisted sequential Monte Carlo procedure. We show that CloneBO optimizes antibodies substantially more efficiently than previous methods in realistic *in silico* experiments and designs stronger and more stable binders in *in vitro* wet lab experiments.
Bayesian optimization, generative model, antibody, biological sequence